MYC and acute myeloid leukemia: In addition, recently, S. Greg Call and colleagues showed that the nuclear receptor encoding gene NR4A1, known as a tumor suppressor in AML, as well as a drug inducing its expression, named Dihydroergotamine, are able to inactivate an oncogenic SE associated with MYC expression.